DAFTAR PUSTAKA

Alexander, M. 1977. Introduction to soil microbiology, 2nd edition. Krieger

Publishing Company. USA.
Atsumi S., Umezawa K., Linuma H., Naganawa H., Litaka Y., Takeuchi T. 1990.
Productio, isolation and structure determination of a novel betaglucosidase inhibitor, cyclophellitol, from Phellinus sp. J. Antibiot 43:4953.
Bailey CJ, Day C. 2003. Antidiabetic drugs. Br J Cardiol; 10 :128-36.
Bu'Lock,J.D.,Hamilton,D.,Hulme,M.A.,Powell,A.J.,Shepherd,D.,Smalley,H.M.an
dSmith,G.N. 1965. Metabolic development and secondary biosynthesis in
Penicilliumurticae. Can.1.Micro.11,765-778.
Bunch AW dan Harris RE. 1986. The Manipulation of Microorganisms for the
Production of Secondary Metabolites. Biotechnology and Genetic
Engineering Review Vol 4.
Chen, H., X. Yan, W. Lin, L. Zheng and W. Zhang. 2004. A new method
for screening alpha glucosidase inhibitors and application to marine
microorganisms. Pharmaceutical Biology. 42: 416-421.
Chisti Yusuf. 1999. Fermentation (industrial) : Production of Oils and Fatty
Acids. Department of Chemical engineering. University of Almeria. Spain
Demain, A.L. and Fang, A. 2000. The natural functions of secondary
metabolites. Adv Biochem Eng Biotechnol. 69: 1-39.
Denbigh, K. G. and J.C.R. Turner. 1971.Chemical Reactor Theory. Cambridge
Univ., Press, Cambridge 3rd edition.
Difco. 2009. Difco & BBL Manual of Microbiological Culture Media Second
Edition. Becton, Dickinson and company. Maryland.
Fischer PB., Yamada H., Shiomi K., Xu Q., Nagai T., Shibata M., Oya I.,
Takahashi Y., Omura S. 1995. New glicosidases inhibitors, panosialins D
and wD produced by Streptomyces sp. OH-5186. J. Antibiot 48: 205-210.
Gandjar, I.G. dan Rohman, A. 2007. Kimia Analisis. Pustaka Pelajar. Yogyakarta.
220 221.
Gepts, W. 1984. The Pathology of Pancreas in Human Diabetes. In: Andreani,
D.et al., ed. Immunology in Diabetes. London. Kimpton.

38

Hakamata W., Kurihara M., Okuda H., Toshiyuki Nishio and Tadatake Oku. 2009.
Design Screening Strategies for Alpha Glucosidase Inhibitors Based on
Enzymological Information. Current Topics in Medicinal Chemistry, 9,3,
12.
Hanefeld, M. 2008. Alpha-glucosidase inhibitors. In B. J. Goldstein dan D.
Muller-Wieland (Ed.). Type 2 diabetes principles and practice second
edition (hlm. 27-43). New York: Informa Healthcare USA Inc.
International Diabetes Federation (IDF). 2013. Executive Summary : IDF
Diabetes Atlas Sixth Edition. ISBN: 2-930229-85-3
Kementrian Kesehatan Republik Indonesia (Kemenkes RI). 2013. Profil
Kesehatan Indonesia 2012. Kemenkes RI. Jakarta
Kim JG, Chang HB, Kwon YI, Moon SK, Chun HS, Ahn SK, Hong CI. 2002.
Novel alpha-glucosidase inhibitors, CKD-711 and CKD-711a produced by
Streptomyces sp. CK-4416. I. Taxonomy, fermentation and isolation. J
Antibiot 55: 457461.
Kimura, A. 2000. Molecular Anatomy of Glucosidase. Trends in Glyoscience
and Glyotechnology 12(68), 373-380.
Krentz, J.A., dan Bailey, J.C. 2005. Review Article : Oral Antidiabetic Agents
Current Role in Type 2 Diabetes Mellitus. Drugs 2005; 65 (3): 385-411
Kusumaningati AM., Nurhatika S., dan Muhibuddin A. 2013. Pengaruh
Konsentrasi Inokulum Bakteri Zymomonas mobilis dan Lama Fermentasi
Pada Produksi Etanol dari Sampah Sayur dan Buah Pasar Wonokromo
Surabaya. Jurnal Sains dan Seni Pomits Vol. 2, No.2, 2337-3520
Kwon OS, Park SH, Yun BS, Pyun YR, Kim CJ. 2001. Cyclo(D-Pro-L-Val), a
specific beta-glucosidase inhibitor produced by Aspergillus sp. F70609. J
Antibiot 54: 179181.
Lebovitz, H. 2004. Oral antidiabetic agents: 2004. Med. Clin. North Am.88,847
863.
Lee JM. 2006. Insulin Resistance in children and adolescent. Rev Endocr Metab
Disord;7: 141-7
MacCracken J. 1997. Puzzles and promises in diabetes management. Postgrad
Med1997;101:138-40,143-5,149-50.
Madigan, M.T., Martinko, J.M., Dunlap, P.V. and Clark, D.P. 2003.
(published February, 2008) Brock Biology of Microorganisms, 12th
edition. Pearson Benjamin-Cummings, San Francisco.
39

Malik, V.S. 1982. Genetics of applied microbiology. Advance in Genetics 20, 37126.
Manaf A. 2008. DPP-4 Inhibitor : A New Pathway in Diabetes Management.
Fakultas Kedokteran Universitas Andalas.
Murray R. K., D. K. Granner dan V. W. Rodwell. 2009. Biokimia Harper.
Jakarta: EGC.
McGown J. Out of Africa: Mysteries of Access and Benefit Sharing.
Washington (USA): The Edmonds Institute; 2006.
Riset Kesehatan Dasar (Riskesdas). 2007. Pedoman Pewawancara Petugas
Pengumpul Data. Jakarta: Badan Litbangkes, Depkes RI.
Riset Kesehatan Dasar (Riskesdas). 2013. Pedoman Pewawancara Petugas
Pengumpul Data. Jakarta: Badan Litbangkes, Depkes RI.
Scheen AJ. 1998. Clinical efficacy of acarbose in diabetes mellitus: a critical
review of controlled trials. Diabetes Metab; 24(4):31120.
Shirling, E.B. and Gottlieb, D. 1966. Methods for characterization of
Streptomycetes species. Int. J. Syst. Bacteriol., 16 : 313 340.
Soumyanath A, Srijayanta S. 2005. In vitro models for assessing antidiabetic
activity. In : Soumyanath A. (Ed). Traditional Medicines for Modern Times.
Antidiabetic Plants. Series traditional Herbal Medicines for Modern Times,
vol 6, CRC press, Glorida. pp.99-116.
Stanbury, Whitaker, dan J.Hall, 2003. Principles of Fermentation Technology
second edition. Buterwoworth Heineman.
Subba, R. 1994. Mikroorganisme Tanah dan Pertumbuhan Tanaman. Jakarta :
Universitas Indonesia.
Sundarmar et al. 1998. Newer Antidiabetic Drug. International Journal Diabetic
Dev. Countries, VOL. 18
Sutedjo M. M. 1996. Mikrobiologi Tanah. Rineka Cipta. Jakarta.
Ten S, dan MacLaren N. 2004. Insulin Resistance Syndrome in Children. J
Clin Endocrinol Metab;89: 2526-39
Terkina et.al. 2002. The biodiversity of actinomycetes in Lake Baikal.
Microbiology 71 (3), 346349.
Volk, W.A dan M.F. Wheeler. 1988. Mikrobiologi Dasar
Jakarta, hal. 149-151.

Jilid 1. Erlangga:

40

Wang et.al. 2011. Optimization of Media Composition and Culture Conditions for
Acarbose Production by Actinoplanes utahensis ZJB-08196. World J.
Microbial Biotechnol 27:2759-2766.
Wang et.al. 2012. Bioactivity-Based HPLC Tandem Q/TOF for AlphaGlucosidase Inhibitors. Screening, Identification, and Quantification from
Actinomycetes. Lat. Am. J. Pharm. 31(5): 693-8 Lat. Am. J. Pharm. 31(5):
693-8
World Health Organization. 2005. Definition and diagnosis of Diabetes Mellitus
and Intermediate Hyperglycemia: Report of a WHO Consultation. diakses
pada tanggal 10 Maret 2014.
World Health Organization. 1999. Definition, diagnosis and classification of
diabetes melitus and its complications: Report of a WHO Consultation.
Part 1. Diakses pada tanggal 10 Maret 2014

41